HK97593A - Tricyclic compounds - Google Patents
Tricyclic compoundsInfo
- Publication number
- HK97593A HK97593A HK975/93A HK97593A HK97593A HK 97593 A HK97593 A HK 97593A HK 975/93 A HK975/93 A HK 975/93A HK 97593 A HK97593 A HK 97593A HK 97593 A HK97593 A HK 97593A
- Authority
- HK
- Hong Kong
- Prior art keywords
- sub
- sup
- nitrogen
- tricyclic compounds
- amide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
- C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858520662A GB8520662D0 (en) | 1985-08-17 | 1985-08-17 | Tricyclic aromatic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK97593A true HK97593A (en) | 1993-09-24 |
Family
ID=10583945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK975/93A HK97593A (en) | 1985-08-17 | 1993-09-16 | Tricyclic compounds |
Country Status (13)
Country | Link |
---|---|
US (1) | US4871865A (xx) |
EP (3) | EP0351887B1 (xx) |
JP (2) | JPH0739346B2 (xx) |
AT (3) | ATE97401T1 (xx) |
DE (3) | DE3650357T2 (xx) |
ES (1) | ES2001519A6 (xx) |
GB (1) | GB8520662D0 (xx) |
GR (1) | GR862137B (xx) |
HK (1) | HK97593A (xx) |
HU (1) | HU201520B (xx) |
IL (1) | IL79729A (xx) |
PT (1) | PT83202B (xx) |
SG (1) | SG38393G (xx) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6310784A (ja) * | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
JPH07116174B2 (ja) * | 1987-02-27 | 1995-12-13 | 協和醗酵工業株式会社 | ジベンズ〔b,e〕オキセピン誘導体 |
AU605501B2 (en) * | 1987-08-25 | 1991-01-17 | Kyowa Hakko Kirin Co., Ltd. | Dibenz(b,e)oxepin derivative and antiallergic agent |
US4882351A (en) * | 1987-10-14 | 1989-11-21 | Roussel Uclaf | Tricyclic compounds |
AU612437B2 (en) * | 1987-12-14 | 1991-07-11 | Kyowa Hakko Kogyo Co. Ltd. | Tricyclic compounds |
US5242931A (en) * | 1988-06-09 | 1993-09-07 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic compounds as TXA2 antagonists |
CA1338625C (en) * | 1988-06-09 | 1996-10-01 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic compounds |
ATE94061T1 (de) * | 1989-06-19 | 1993-09-15 | Wellcome Found | Arylsubstituierte aminderivate verwendbar in der krebstherapie. |
GB8914060D0 (en) * | 1989-06-19 | 1989-08-09 | Wellcome Found | Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
GB8914061D0 (en) * | 1989-06-19 | 1989-08-09 | Wellcome Found | Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
US5208238A (en) * | 1989-06-19 | 1993-05-04 | Burroughs Wellcome Company | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
GB8914040D0 (en) * | 1989-06-19 | 1989-08-09 | Wellcome Found | Agents for potentiating the effects of antitumour agents and combating multiple drug resistance |
EP0522460A3 (en) * | 1991-07-09 | 1993-03-24 | Sumitomo Electric Industries, Ltd. | Semiconductor device testing apparatus |
US5641805A (en) * | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
US5899727A (en) | 1996-05-02 | 1999-05-04 | Advanced Micro Devices, Inc. | Method of making a semiconductor isolation region bounded by a trench and covered with an oxide to improve planarization |
DE19848200A1 (de) * | 1998-10-20 | 2000-04-27 | Basf Ag | Verfahren zur Trocknung von Phenoxymethylbenzoesäuren |
US6174914B1 (en) | 1999-06-15 | 2001-01-16 | Alcon Laboratories, Inc. | Method of inhibiting cytokine release from human ocular cells |
US6420399B1 (en) | 1999-06-18 | 2002-07-16 | Alcon Manufacturing, Ltd. | Topical ophthalmic mast cell stabilizers for treating allergic eye disease |
US6174878B1 (en) | 1999-08-31 | 2001-01-16 | Alcon Laboratories, Inc. | Topical use of kappa opioid agonists to treat otic pain |
US20040097486A1 (en) * | 1999-11-18 | 2004-05-20 | Yanni John M. | Use of an H1 antagonist and a safe steroid to treat eye conditions |
EP1250133B1 (en) | 2000-01-25 | 2005-03-30 | Alcon Inc. | Ophthalmic anti-allergy compositions suitable for use with contact lenses |
AU5567501A (en) | 2000-05-19 | 2001-12-03 | Alcon Universal Ltd | Disulfide derivatives useful for treating allergic diseases |
EP1284722B1 (en) | 2000-05-19 | 2005-08-24 | Alcon Inc. | Compositions containing a benzamide disulfide derivative for treating allergic diseases |
ES2222370T3 (es) | 2000-05-19 | 2005-02-01 | Alcon Inc. | Derivados de disulfuro de anilina para tratar enfermedades alergicas. |
US7977376B2 (en) * | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
TWI231759B (en) | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
EP1467762B1 (en) * | 2001-12-05 | 2006-02-08 | Alcon, Inc. | Use of a h1 antagonist and rimexolone as a safe steroid to treat rhinitis |
US20050209312A1 (en) * | 2004-03-19 | 2005-09-22 | Bausch & Lomb Incorporated | Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative |
CN1976694A (zh) * | 2004-06-28 | 2007-06-06 | 爱尔康公司 | 用于治疗变应性疾病的局部用制剂 |
ES2253996B1 (es) * | 2004-07-28 | 2007-08-16 | Urquima, S.A. | Procedimiento para la preparacion del acido 11-((z)-3-(dimetilamino)propiliden)-6,11-dihidrodibenz(b,e)oxepinacetico. |
MX2007005845A (es) * | 2004-11-24 | 2007-07-04 | Alcon Inc | Metodo para entregar rocio nasal. |
US20100137619A1 (en) | 2005-12-22 | 2010-06-03 | Medichem, S.A. | Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation |
US7950020B2 (en) * | 2006-03-16 | 2011-05-24 | Ntt Docomo, Inc. | Secure operating system switching |
US7687646B2 (en) * | 2006-03-28 | 2010-03-30 | Azad Pharmaceutical Ingredients, Ag | Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof |
US8445437B2 (en) * | 2006-07-27 | 2013-05-21 | The Brigham And Women's Hospital, Inc. | Treatment and prevention of cardiovascular disease using mast cell stabilizers |
US20080139531A1 (en) * | 2006-12-04 | 2008-06-12 | Alcon Manufacturing Ltd. | Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair |
AU2007346121B2 (en) | 2007-02-07 | 2012-08-23 | Novartis Ag | Olopatadine formulations for topical nasal administration |
CH698773B1 (de) * | 2007-02-16 | 2011-06-30 | Sumitomo Chemical Co | Verfahren zur Herstellung einer Dibenzoxepin-Verbindung. |
EP2131834A2 (en) * | 2007-04-11 | 2009-12-16 | Alcon Research, Ltd. | Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
JP5460600B2 (ja) | 2007-09-28 | 2014-04-02 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | 肥満症治療における肥満細胞安定化薬 |
SI2279159T1 (sl) * | 2008-03-20 | 2014-04-30 | Lek Pharmaceuticals D.D. | 2-halobifenil-4-il intermediati v sintezi angiotensin II antagonistov |
US10517839B2 (en) * | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
EP2145882B1 (en) | 2008-07-16 | 2013-08-21 | Crystal Pharma, S.A.U. | Process for obtaining olopatadine and intermediates |
CN102292326B (zh) | 2009-02-05 | 2015-04-22 | Zach系统股份公司 | 奥洛他定和/或其药学上可接受的盐的制备方法 |
IT1397503B1 (it) | 2009-04-21 | 2013-01-16 | F S I Fabbrica Italiana Sint | Processo per la preparazione di olopatadina |
CN104173273A (zh) * | 2009-07-17 | 2014-12-03 | 爱尔康研究有限公司 | 儿童用奥洛他定鼻腔喷雾方案 |
WO2011027322A1 (en) | 2009-09-03 | 2011-03-10 | Ranbaxy Laboratories Limited | Extended release dosage form containing olopatadine for oral administration |
CN102548536A (zh) * | 2009-10-01 | 2012-07-04 | 爱尔康研究有限公司 | 奥洛他定组合物及其用途 |
TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠(olopatadine)眼用組成物 |
US9145383B2 (en) | 2012-08-10 | 2015-09-29 | Hallstar Innovations Corp. | Compositions, apparatus, systems, and methods for resolving electronic excited states |
US9867800B2 (en) | 2012-08-10 | 2018-01-16 | Hallstar Innovations Corp. | Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen |
US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
RS62383B1 (sr) | 2013-09-13 | 2021-10-29 | Glenmark Specialty Sa | Stabilna farmaceutska kompozicija sa fiksnom dozom koja sadrži mometazon i olopatadin za nazalnu primenu |
US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
JP6419195B2 (ja) | 2013-10-04 | 2018-11-07 | グレンマーク・スペシャルティー・エスエー | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 |
US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
WO2015120389A1 (en) | 2014-02-10 | 2015-08-13 | Patara Pharma, LLC | Mast cell stabilizers treatment for systemic disorders |
PT3104854T (pt) | 2014-02-10 | 2020-06-26 | Respivant Sciences Gmbh | Estabilizadores de mastócitos para tratamento de doença pulmonar |
US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
US10265296B2 (en) | 2015-08-07 | 2019-04-23 | Respivant Sciences Gmbh | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
US10238625B2 (en) | 2015-08-07 | 2019-03-26 | Respivant Sciences Gmbh | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
WO2018044942A1 (en) | 2016-08-31 | 2018-03-08 | Patara Pharma, LLC | Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis |
JP2019531308A (ja) | 2016-10-07 | 2019-10-31 | レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングRespivant Sciences Gmbh | 肺線維症の治療のためのクロモリン組成物 |
KR20200125625A (ko) | 2018-02-23 | 2020-11-04 | 글렌마크 스페셜티 에스. 에이. | 모메타손 및 올로파타딘의 조합을 사용하는 소아 대상체의 알레르기성 비염의 치료 |
US20220387408A1 (en) | 2019-11-12 | 2022-12-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL58901C (xx) * | 1957-02-07 | 1947-02-15 | ||
DE1232161B (de) * | 1961-10-07 | 1967-01-12 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung von basisch substituierten Dibenzo-oxepinen und deren Salzen |
BE641498A (xx) * | 1962-03-13 | |||
US3401192A (en) * | 1962-07-17 | 1968-09-10 | Merck & Co Inc | Esters of 5h-dibenzo [a, d] cycloheptene |
US3420851A (en) * | 1962-12-19 | 1969-01-07 | Pfizer & Co C | Novel dibenzoxepines |
US3509175A (en) * | 1963-10-14 | 1970-04-28 | Pfizer & Co C | Recovery of pure cis 11-(3-dimethylaminopropylidene) - 6,11 - dihydrodibenz(b,e)oxepine from admixture with its trans isomer |
GB1076612A (en) * | 1964-07-24 | 1967-07-19 | Merck & Co Inc | Dibenzocycloheptene derivatives |
FR2138257B1 (xx) * | 1971-05-21 | 1974-08-23 | Roussel Uclaf | |
OA04603A (fr) * | 1973-03-02 | 1980-06-30 | Rhone Poulenc Sa | Nouveaux dérivés du dibenzo [a,d] cycloheptene, leurs sels et leur préparation. |
US3966820A (en) * | 1974-07-05 | 1976-06-29 | Syntex (U.S.A.) Inc. | 2-Substituted-5-oxo-5H-dibenzo-[A,D]cycloheptenes, the esters and ethers thereof, having pharmaceutical activity, and methods and compositions for the use thereof |
JPS5139683A (ja) * | 1974-10-02 | 1976-04-02 | Dai Ichi Kogyo Seiyaku Co Ltd | Jibenzookisebinjudotaino seizoho |
JPS5516590A (en) * | 1978-07-21 | 1980-02-05 | Nec Corp | Television relay broadcasting equipment |
US4282365A (en) * | 1978-11-24 | 1981-08-04 | Merck & Co., Inc. | Dibenz[b,e]oxepin compounds |
US4223013A (en) * | 1978-12-29 | 1980-09-16 | Syva Company | Amitriptyline conjugates to antigenic proteins and enzymes |
US4307245A (en) * | 1978-12-29 | 1981-12-22 | Syva Company | Amitriptyline conjugates to antigenic proteins and enzymes |
JPS56156273A (en) * | 1980-03-31 | 1981-12-02 | Dainippon Pharmaceut Co Ltd | Acetic derivative |
US4412999A (en) * | 1982-04-14 | 1983-11-01 | Merck & Co., Inc. | Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds |
JPS6028972A (ja) * | 1983-06-29 | 1985-02-14 | Kyowa Hakko Kogyo Co Ltd | ジベンゾ[b,e]オキセピン誘導体 |
-
1985
- 1985-08-17 GB GB858520662A patent/GB8520662D0/en active Pending
-
1986
- 1986-08-07 US US06/894,306 patent/US4871865A/en not_active Expired - Lifetime
- 1986-08-14 PT PT83202A patent/PT83202B/pt unknown
- 1986-08-14 GR GR862137A patent/GR862137B/el unknown
- 1986-08-14 ES ES8601122A patent/ES2001519A6/es not_active Expired
- 1986-08-15 EP EP89115497A patent/EP0351887B1/en not_active Expired - Lifetime
- 1986-08-15 EP EP86306326A patent/EP0214779B1/en not_active Expired - Lifetime
- 1986-08-15 DE DE3650357T patent/DE3650357T2/de not_active Expired - Lifetime
- 1986-08-15 IL IL79729A patent/IL79729A/xx not_active IP Right Cessation
- 1986-08-15 EP EP88121224A patent/EP0316022B1/en not_active Expired - Lifetime
- 1986-08-15 DE DE88121224T patent/DE3689311T2/de not_active Expired - Lifetime
- 1986-08-15 DE DE8686306326T patent/DE3670290D1/de not_active Expired - Lifetime
- 1986-08-15 AT AT88121224T patent/ATE97401T1/de not_active IP Right Cessation
- 1986-08-15 JP JP61191577A patent/JPH0739346B2/ja not_active Expired - Lifetime
- 1986-08-15 AT AT89115497T patent/ATE125535T1/de not_active IP Right Cessation
- 1986-08-15 HU HU863592A patent/HU201520B/hu unknown
- 1986-08-15 AT AT86306326T patent/ATE51867T1/de not_active IP Right Cessation
-
1993
- 1993-04-06 SG SG383/93A patent/SG38393G/en unknown
- 1993-09-16 HK HK975/93A patent/HK97593A/xx not_active IP Right Cessation
-
1994
- 1994-09-08 JP JP6240644A patent/JP2556821B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0351887B1 (en) | 1995-07-26 |
GB8520662D0 (en) | 1985-09-25 |
DE3689311T2 (de) | 1994-03-10 |
EP0351887A1 (en) | 1990-01-24 |
IL79729A (en) | 1990-11-05 |
HUT41761A (en) | 1987-05-28 |
EP0316022A3 (en) | 1989-10-11 |
IL79729A0 (en) | 1986-11-30 |
DE3670290D1 (de) | 1990-05-17 |
DE3650357D1 (de) | 1995-08-31 |
US4871865A (en) | 1989-10-03 |
GR862137B (en) | 1986-12-30 |
PT83202A (en) | 1986-09-01 |
ES2001519A6 (es) | 1988-06-01 |
SG38393G (en) | 1993-06-11 |
DE3689311D1 (de) | 1993-12-23 |
JP2556821B2 (ja) | 1996-11-27 |
ATE51867T1 (de) | 1990-04-15 |
JPH07165749A (ja) | 1995-06-27 |
EP0214779B1 (en) | 1990-04-11 |
EP0316022A2 (en) | 1989-05-17 |
DE3650357T2 (de) | 1996-01-04 |
EP0316022B1 (en) | 1993-11-18 |
HU201520B (en) | 1990-11-28 |
JPH0739346B2 (ja) | 1995-05-01 |
PT83202B (pt) | 1989-03-30 |
ATE97401T1 (de) | 1993-12-15 |
EP0214779A1 (en) | 1987-03-18 |
ATE125535T1 (de) | 1995-08-15 |
JPS6245557A (ja) | 1987-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8520662D0 (en) | Tricyclic aromatic compounds | |
DK126389D0 (da) | Peptidforbindelser | |
ES8500233A1 (es) | Un metodo para preparar compuestos de piridilo | |
ES8506673A1 (es) | Un metodo para preparar derivados de fenotiazina | |
GB1465769A (en) | Carbamates of ergolines | |
GB8515212D0 (en) | Thiazolidine derivatives | |
ES8800206A1 (es) | Un procedimiento para preparar derivados de 2-aminopirimidinona | |
AU586089B2 (en) | Phosphodiesterace type 111 inhibitors having a thiadiazinone ring as part of a tricyclic structure | |
ES8600762A1 (es) | Un procedimiento para la preparacion de nuevos compuestos de beta-lactama. | |
ES8506313A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo(3.2.0)hepteno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20060814 |